Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Biofrontera reports rise in Q4 revenue, turns profitable

businessinsider

Mar 19, 2026 at 07:27 PM

Biofrontera reports rise in Q4 revenue, turns profitable

Login to unlock56characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

Apr 20, 2026 at 06:34 PMEli Lilly Announces $7 Billion Acquisition of Kelonia: Pioneering the 'In Vivo CAR-T' Frontier and Leading Gene Therapy …
Apr 1, 2026 at 11:11 PMEli Lilly's Oral Weight-Loss Drug Foundayo Approved, the Only One That Can Be Taken Anytime Without Fasting
Mar 26, 2026 at 07:03 AMThe Reality and Illusion of "AI Drug Discovery" XTALPI's Turnaround
Mar 23, 2026 at 12:09 PMStrong US Market! WuXi AppTec's 2025 Net Profit Attributable to the Parent Company Surged 105.2%, 2026 Revenue Growth Ex…
Mar 20, 2026 at 03:28 AMAfter the "glass glue war," GIANT BIOGENE shows its first signs of growth anxiety

Related Stocks

Biofrontera AG

DEB8F

BIOFRONTERA INC C/WTS 27/10/2026 (TO PUR COM)

USBFRIW

-1.48%

First Trust NYSE Arca Biotech Index Fd

USFBT

LongbridgeAI